March 19, 2020 / 5:58 PM / 9 days ago

BRIEF-Moody's Says Approval Of Any New Pharmaceutical Products To Fight Coronavirus Pandemic Would Be Credit Positive For Companies Involved

March 19 (Reuters) - Moody’s

* MOODY’S SAYS APPROVAL OF ANY NEW PHARMACEUTICAL PRODUCTS TO FIGHT CORONAVIRUS PANDEMIC WOULD BE CREDIT POSITIVE FOR COMPANIES INVOLVED

* MOODY’S SAYS DEVELOPMENT OF CORONAVIRUS-RELATED PRODUCTS HAS POSITIVE IMPLICATIONS FOR PHARMACEUTICAL INDUSTRY FROM AN ESG PERSPECTIVE

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below